Recalcati (2020), for example, reported that 20.4% of 88 COVID‐19 patients presented cutaneous manifestations such as erythematous rash, generalized urticaria and vesicles. They suggested that the skin lesions were similar to ones found in common viral diseases but emphasized that additional studies are necessary to confirm its association with COVID‐19.